Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:IVC

Invacare (IVC) Stock Price, News & Analysis

Invacare logo

About Invacare Stock (NYSE:IVC)

Key Stats

Today's Range
N/A
50-Day Range
$0.35
$0.74
52-Week Range
N/A
Volume
33,301 shs
Average Volume
240,305 shs
Market Capitalization
$20.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

IVC Stock News Headlines

The latest trend in real estate
These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.
Buckeye Trail coasts past Newcomerstown for key IVC win
IL&FS Investment Managers Limited (IVC.NS)
See More Headlines

IVC Stock Analysis - Frequently Asked Questions

Invacare Co. (NYSE:IVC) announced its quarterly earnings results on Wednesday, October, 27th. The health services provider reported ($0.12) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.08. The health services provider earned $224.20 million during the quarter, compared to the consensus estimate of $222.27 million. Invacare had a negative trailing twelve-month return on equity of 37.76% and a negative net margin of 9.99%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invacare investors own include Pfizer (PFE), Intel (INTC), Exxon Mobil (XOM), Micron Technology (MU), Occidental Petroleum (OXY), Devon Energy (DVN) and Global Blood Therapeutics (GBT).

Company Calendar

Last Earnings
10/27/2021
Today
11/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
CUSIP
46120310
Employees
3,000
Year Founded
1885

Profitability

Net Income
$-45,560,000.00
Pretax Margin
-9.38%

Debt

Sales & Book Value

Annual Sales
$872.46 million
Book Value
$5.54 per share

Miscellaneous

Free Float
35,153,000
Market Cap
$20.01 million
Optionable
Optionable
Beta
0.38

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:IVC) was last updated on 11/28/2024 by MarketBeat.com Staff
From Our Partners